GCL
EUCR

Glazer Capital LLC’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Glazer Capital LLC’s Portfolio EUCR Stock Details EUCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,022,411
Closed -$10.2M – 614
2022
Q3 		$10.2M Buy
1,022,411
+696,605
+214% +$6.98M 0.19% 170
2022
Q2 		$3.22M Buy
325,806
+258,841
+387% +$2.56M 0.08% 274
2022
Q1 		$659K Sell
66,965
-25
-0% -$246 0.02% 352
2021
Q4 		$654K Buy
+66,990
New +$654K 0.02% 461